ARVN Q1 2022 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$907M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+381.8% YoY

Gross Profit

$24M92.1% margin

Operating Income

-$58M-217.7% margin

Net Income

-$63M-239.2% margin

EPS (Diluted)

$-1.20

QoQ Revenue Growth

+0.8%

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$59M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$765M

Stockholders' Equity

$723M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$6M	+381.8%
Gross Profit	$24M	$6M	+343.6%
Operating Income	-$58M	-$42M	-38.4%
Net Income	-$63M	-$41M	-54.6%